Literature DB >> 16386687

Coronary stent thrombosis in the current drug-eluting stent era: insights from the ERACI III trial.

Alfredo E Rodriguez, Juan Mieres, Carlos Fernandez-Pereira, Cesar F Vigo, Maximo Rodriguez-Alemparte, Daniel Berrocal, Liliana Grinfeld, Igor Palacios.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16386687     DOI： 10.1016/j.jacc.2005.10.016

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  11 in total

1.  Advantages and disadvantages of biodegradable platforms in drug eluting stents.

Authors:  Agustina Rodriguez-Granillo; Bibiana Rubilar; Gaston Rodriguez-Granillo; Alfredo E Rodriguez
Journal:  World J Cardiol       Date:  2011-03-26

2.  PCI or CABG: which patients and at what cost?

Authors:  Tony Gershlick; Martyn Thomas
Journal:  Heart       Date:  2007-10       Impact factor: 5.994

3.  [Patients with coronary artery stents: when and how should operations be carried out?].

Authors:  W Rottbauer; H A Katus
Journal:  Chirurg       Date:  2009-06       Impact factor: 0.955

4.  Very late bare metal stent thrombosis with concomitant patent drug eluting stent in the same vessel: a case for a suggestive hypothesis.

Authors:  Gaetano Tanzilli; Alessio Arrivi; Martina Sordi; Herribert Pavaci; Attilio Placanica; Enrico Mangieri
Journal:  BMJ Case Rep       Date:  2009-09-01

5.  Selective versus exclusive use of drug-eluting stents in treating multivessel coronary artery disease: a real-world cohort study.

Authors:  Arsha Karbassi; Seyed Ebrahim Kassaian; Hamidreza Poorhosseini; Mojtaba Salarifar; Arash Jalali; Ebrahim Nematipour; Elham Hakki Kazazi; Mohammad Alidoosti; Ali Mohammad Hajizeinali; Masoumeh Lotfi Tokaldani
Journal:  Tex Heart Inst J       Date:  2014-10-01

6.  Bridging therapy for early surgery in patients on dual antiplatelet therapy after drug-eluting stent implantation.

Authors:  E G Marcos; A C Da Fonseca; S H Hofma
Journal:  Neth Heart J       Date:  2011-10       Impact factor: 2.380

Review 7.  Drug-eluting stent thrombosis 1,659 days after stent deployment: case report and literature review.

Authors:  Anthony Al-Dehneh; Hartaj Virk; Yazan Alkhouri; Aiman Hamdan; Mahesh Bikkina
Journal:  Tex Heart Inst J       Date:  2010

8.  Rapamycin inhibits re-endothelialization after percutaneous coronary intervention by impeding the proliferation and migration of endothelial cells and inducing apoptosis of endothelial progenitor cells.

Authors:  Hai-Tao Liu; Fei Li; Wen-Yong Wang; Xiao-Jing Li; Yi-Meng Liu; Rui-An Wang; Wen-Yi Guo; Hai-Chang Wang
Journal:  Tex Heart Inst J       Date:  2010

Review 9.  Providing perioperative care for patients with hip fractures.

Authors:  G T C Wong; N C H Sun
Journal:  Osteoporos Int       Date:  2010-11-06       Impact factor: 4.507

10.  Intramural delivery of rapamycin with alphavbeta3-targeted paramagnetic nanoparticles inhibits stenosis after balloon injury.

Authors:  Tillmann Cyrus; Huiying Zhang; John S Allen; Todd A Williams; Grace Hu; Shelton D Caruthers; Samuel A Wickline; Gregory M Lanza
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-02-21       Impact factor: 8.311
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.